CN Patent

CN103467423B — 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法

Assigned to Boehringer Ingelheim International GmbH · Expires 2016-03-16 · 10y expired

What this patent protects

本发明涉及通式I的吡喃葡萄糖基取代的苯衍生物，其中R 1 至R 6 与R 7a 、R 7b 、R 7c 基如权利要求1所定义，包括互变异构体、其立体异构体、其混合物及其盐；涉及通式I化合物的制备方法和中间体；以及涉及本发明化合物治疗代谢病症的用途。

USPTO Abstract

本发明涉及通式I的吡喃葡萄糖基取代的苯衍生物，其中R 1 至R 6 与R 7a 、R 7b 、R 7c 基如权利要求1所定义，包括互变异构体、其立体异构体、其混合物及其盐；涉及通式I化合物的制备方法和中间体；以及涉及本发明化合物治疗代谢病症的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103467423B
Jurisdiction
CN
Classification
—
Expires
2016-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.